Moderna has agreed to pay up to $2.25 billion to settle a long-running legal dispute with Arbutus Biopharma and Genevant

Stay informed with BioPharma Dive’s free newsletter, delivered straight to your inbox. In the world of drug development, business deals

Merck & Co. has long been known for its cancer drug Keytruda. But with Keytruda’s patents set to expire soon,

Nonprofit organizations are playing a big role in developing treatments for rare diseases, especially when big companies aren’t interested. Gene

Super Bowl ads often set cultural trends, and this year, AI was a hot topic with about 23% of commercials

Novo Nordisk, a big name in pharmaceuticals, has teamed up with a smaller company called Vivtex. This partnership aims to

Gilead has shared new results from its ARTISTRY-1 and ARTISTRY-2 trials, which looked at how well a new combination of

Axol Bioscience has bought the eye research part of Newcells Biotech. This deal helps Axol offer more types of lab-grown